IGM Biosciences to Present at the Guggenheim 2022 Oncology Conference

Rhea-AI Summary

IGM Biosciences, Inc. (Nasdaq: IGMS) has announced that CEO Fred Schwarzer will present virtually at the Guggenheim 2022 Oncology Conference on February 10, 2022, at 1:00 p.m. EST. A live webcast will be available on the company's website, with a replay accessible for 90 days post-event. IGM Biosciences, based in Mountain View, California, focuses on developing engineered IgM antibodies, addressing challenges in therapeutic use since 2010. The company's proprietary IgM technology platform aims to yield advantages over traditional IgG antibodies.

MOUNTAIN VIEW, Calif., Feb. 03, 2022 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced that Fred Schwarzer, Chief Executive Officer, will present virtually at the Guggenheim 2022 Oncology Conference on Thursday, February 10, 2022 at 1:00 p.m. EST.

A live webcast of the event will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investor.igmbio.com/news-and-events/events-and-presentations. A replay of the webcast will be archived on the Company’s website for 90 days following the presentation.

About IGM Biosciences, Inc.
Headquartered in Mountain View, California, IGM Biosciences is a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies. Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. Through its efforts, IGM Biosciences has created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent properties may provide advantages as compared to IgG antibodies.

Contact
Argot Partners
David Pitts
212-600-1902
igmbio@argotpartners.com

FAQ

When will IGM Biosciences present at the Guggenheim 2022 Oncology Conference?

IGM Biosciences will present on February 10, 2022, at 1:00 p.m. EST.

Where can I watch the IGM Biosciences conference presentation?

The presentation can be watched live on the 'Events and Presentations' page of the IGM Biosciences website.

How long will the IGM Biosciences presentation replay be available?

The replay of the presentation will be available for 90 days following the event.

What is the focus of IGM Biosciences?

IGM Biosciences focuses on creating and developing engineered IgM antibodies for therapeutic use.

What is the significance of IgM antibodies over IgG antibodies?

IGM Biosciences' IgM antibodies may offer advantages in certain clinical indications compared to IgG antibodies.